Braak stage 1, 100% of pigmented neurons left
parkinsonconnecting

Gene record

SPATA22

spermatogenesis associated 22

translation score 0.42, read 2026-10-23; 2 sealed predictions, 0 held; 3 receipts.

Six readers

readerfoundscore
genetics
Open Targets
genetic association 0.03 (overall 0.02)0.03
cell type
Human Protein Atlas
cell type enhanced, including oligodendrocytes; strongest in late primary spermatocytes0.75
chemistry
Open Targets
hard to drug0.00
trials
ClinicalTrials.gov
no Parkinson's trials on record: an open field1.00
literature
PubMed
no papers tie it to Parkinson's yet1.00
pathways
Reactome
in no curated pathway0.00

No case: the score is under the bar. Receipt 7670

Sealed predictions

  1. SPATA22 in oligodendrocytes, braak+0.52 (p 0.150) → -0.66 (p 0.054)receipt 7677
  2. SPATA22 in dopamine neurons, braak-0.16 (p 0.689) → +0.03 (p 0.946)receipt 7678

Swarm cases

receipt 7678: SPATA22 in dopamine neurons, braak

power
full sample -0.02 (p 0.942, n 18), 95% CI -0.48 to +0.45. the interval is wide: not enough donors to tell.
confounder
adjusted for sex: -0.05 (p 0.840, n 18). does not hold up.
composition
dopamine neurons share of nuclei vs axis +0.05 (p 0.854); controlling for it: -0.07 (p 0.787, n 18). could be the mix.
skeptic
leave-one-out range -0.12 to +0.10, sign flips 7; without severely affected donors -0.02 (p 0.942, n 18). fragile.
cell type
no other cell group does better.
axis
no measure beats "tracks Braak Lewy-body stage" for SPATA22 in dopamine neurons.

case closed: nothing better to follow up.

receipt 7677: SPATA22 in oligodendrocytes, braak

power
full sample -0.10 (p 0.702, n 18), 95% CI -0.54 to +0.39. the interval is wide: not enough donors to tell.
confounder
adjusted for sex: -0.17 (p 0.504, n 18). does not hold up.
composition
oligodendrocytes share of nuclei vs axis +0.03 (p 0.915); controlling for it: -0.25 (p 0.323, n 18). could be the mix.
skeptic
leave-one-out range -0.21 to +0.04, sign flips 3; without severely affected donors -0.10 (p 0.702, n 18). fragile.
cell type
no other cell group does better.
axis
no measure beats "tracks Braak Lewy-body stage" for SPATA22 in oligodendrocytes.

case closed: nothing better to follow up.

Receipts

loading the receipts